Position in TMO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,989,396
+$141,735 QoQ
Shares Held
3,968
+5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#1,182
of 2,606 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Harfst & Associates, Inc. holds $2,311,688 across 2 Diagnostics & Research names. TMO ranks #1 (86.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
3,968 | $1,989,396 | |
| 2 | DHR |
Danaher Corp /De/
|
1,692 | $322,292 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,989,396 | 3,968 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,847,661 | 3,759 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,001,999 | 3,455 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,689,324 | 3,483 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,390,727 | 3,430 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $601,598 | 1,209 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||